Encap Drug Delivery has collaborated with Lena Nanoceutics to develop Nano-Capsules, a new drug delivery technology that integrates Lena’s proprietary nano-particle engineering technology with Encap’s liquid-filled hard capsule technology.

Preliminary in vitro data produced using itraconazole revealed that both nano-particulate and liquid fill formulations have an improved dissolution rate compared with standard particulate drug formulations.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

When the two were combined, a greater improvement was seen.

Liquid-fill formulations can be solutions or suspensions of drug in non-aqueous liquids, found to generate increased bioavailability of the active drug.

The nano-capsule technology results in a decrease in particle size and an increased surface area, hence a faster dissolution.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Recognised with 2025 Excellence Awards for Research and Development and Marketing , Novotech converted FDA/EMA fast track designations into faster HDV trial timelines while translating complex HBV science into sponsor ready insights. Discover how this dual strength in execution and communication is reshaping liver disease clinical development.

Discover the Impact